This provider averages 82 services per working day
Based on 204.5K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $34.8M in total Medicare payments ranks in the 99th percentile of Ophthalmology providers nationally.
Averaging 82 services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $417.54 | $187.28 | 2.23x | $230.26 | $3.2M | 17.2K | 16 |
| 2015 | $406.76 | $185.64 | 2.19x | $221.12 | $3.1M | 16.9K | 17 |
| 2016 | $390.48 | $182.20 | 2.14x | $208.28 | $3.2M | 17.3K | 17 |
| 2017 | $444.52 | $208.59 | 2.13x | $235.93 | $3.7M | 17.8K | 18 |
| 2018 | $470.60 | $216.89 | 2.17x | $253.71 | $3.5M | 16.1K | 16 |
| 2019 | $460.60 | $203.73 | 2.26x | $256.87 | $3.3M | 16.4K | 17 |
| 2020 | $491.72 | $216.96 | 2.27x | $274.76 | $3.5M | 15.9K | 16 |
| 2021 | $495.07 | $216.37 | 2.29x | $278.70 | $3.5M | 16.0K | 18 |
| 2022 | $381.49 | $168.24 | 2.27x | $213.25 | $3.7M | 22.3K | 20 |
| 2023 | $215.86 | $84.97 | 2.54x | $130.89 | $4.1M | 48.6K | 19 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 27.4K | $20.4M | $742.88 | 1.87x |
| J2778 | Injection, ranibizumab, 0.1 mg | 17.5K | $4.8M | $277.08 | 2.53x |
| 67028 | Injection of drug into eye | 21.7K | $1.9M | $87.01 | 3.80x |
| 92012 | Established patient problem focused exam of visual system | 25.4K | $1.6M | $63.28 | 2.88x |
| 92134 | Imaging of retina | 36.2K | $1.1M | $31.69 | 3.15x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 38.5K | $1.1M | $29.03 | 1.95x |
| J3590 | Unclassified biologics | 287 | $485.4K | $1.7K | 1.87x |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1.9K | $405.0K | $217.84 | 3.73x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 5.3K | $361.5K | $67.58 | 2.37x |
| J3490 | Unclassified drugs | 198 | $349.5K | $1.8K | 2.38x |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 3.5K | $285.7K | $80.94 | 3.06x |
| 92014 | Established patient complete exam of visual system | 3.1K | $262.9K | $85.63 | 3.06x |
| 92250 | Photography of the retina | 6.5K | $256.0K | $39.24 | 4.32x |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | 211 | $198.1K | $938.98 | 2.90x |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 1.1K | $171.3K | $155.91 | 1.92x |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1.4K | $166.1K | $120.36 | 2.24x |
| J7999 | Compounded drug, not otherwise classified | 2.6K | $159.4K | $61.75 | 2.23x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 1.2K | $144.2K | $120.24 | 3.01x |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 690 | $119.3K | $172.85 | 2.95x |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | 100 | $95.3K | $953.22 | 3.79x |
This provider submits charges 2.26 times higher than what Medicare actually pays.
A markup ratio of 2.26x means for every $100 Medicare pays, this provider initially charges $226. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in WA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Charles Sung, MD | Kennewick, WA | $38.3M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data